Mandate

Vinge has advised CELLINK AB (publ) in connection with its listing on Nasdaq Stockholm

April 20, 2020

Vinge has advised CELLINK AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm Main Market, with an estimated market capitalisation of approximately SEK 4.1 billion. The prospectus was published on 15 April 2020 and the trading on Nasdaq Stockholm commenced on 20 April 2020.

CELLINK is a niche life-science company developing and delivering life-science solutions for cell culturing. CELLINK focus on three application areas including bioprinting, analysis and liquid handling & bioprocessing. The target is to develop and commercialise cell culture technologies, enabling researchers to 3D-print human organs and tissues for pharmaceutical and cosmetic applications.

Vinge’s team has primarily consisted of Anders Strid, Wibeke Sorling, Edin Agic and Johanna Hamrefält (Capital Markets and Public M&A) as well as Victor Ericsson and Emelie Svanberg (Corporate Tax).

Anti-counterfeiting – the best way to work to counteract trademark infringement and counterfeiting

Counterfeiting and intellectual property law infringement constitute significant problems for both individual trademarks and companies as well as from a broader societal perspective. In this year’s edition of WTR’s “Anti-Counterfeiting: A Global Guide” we present the most important parts of the Swedish legislation, as well as how companies can create successful preventive measures.
June 07, 2021

Full service within IP gives top ranking

Vinge's IP team has been ranked in the top band by the international guide IP Stars in two areas; Trade mark contentious and Trade mark prosecution - law firms.
May 21, 2021

Extensive amendments to the Swedish Protective Security Act - increased obligations and a comprehensive sanctions system

Extensive amendments to the Swedish Protective Security, which include increased obligations for operators of security-sensitive activities and a comprehensive sanctions system, are proposed to enter into force on 1 December 2021. These changes, which were presented in a Government bill of 18 March 2021, generate new and far-reaching obligations for many companies, especially in view of the severe sanctions that may be imposed if the obligations are not complied with.
May 19, 2021